HIC
ABBV icon

Hamrick Investment Counsel’s AbbVie ABBV Stock Holding History

Hamrick Investment Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.2K Sell
100
-85
-46% -$18.3K 0.02% 115
2026
Q1 		$40.2K Buy
185
+85
+85% +$18.9K 0.02% 164
2025
Q4 		$22.8K Buy
+100
New +$22.8K 0.02% 110

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hamrick Investment Counsel's ABBV Position: Q2 2026 in Review

Hamrick Investment Counsel reduced its AbbVie (ABBV) stake by 46% in Q2 2026, selling an estimated $18.3K and leaving 100 shares worth $25.2K. The position accounts for 0.02% of the portfolio, ranked #115.

Hamrick Investment Counsel first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $40.2K in Q1 2026. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Hamrick Investment Counsel held 100 shares of AbbVie worth $25.2K as of Q2 2026.
  • Hamrick Investment Counsel sold 85 AbbVie shares in Q2 2026, an estimated $18.3K.
  • AbbVie made up 0.02% of Hamrick Investment Counsel's portfolio in Q2 2026, its #115 holding.
  • Hamrick Investment Counsel first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • Hamrick Investment Counsel's AbbVie position peaked at $40.2K in Q1 2026.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hamrick Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.